Biora Therapeutics, Inc. (BIORQ) vs Eiger BioPharmaceuticals, Inc. (EIGRQ)

Biora Therapeutics, Inc. and Eiger BioPharmaceuticals, Inc. are both Biotechnology companies. Biora Therapeutics, Inc. and Eiger BioPharmaceuticals, Inc. are of similar size ($2.6M and $2.5M). Biora Therapeutics, Inc. grew revenue faster over the last twelve months: 347.0% against 17.0%. Eiger BioPharmaceuticals, Inc. has the higher net margin (−475.3% vs −3,527.9%) and the lower return on invested capital (−3,674.6% vs 0.00%). Across the 15 metrics below, Eiger BioPharmaceuticals, Inc. leads on 9 and Biora Therapeutics, Inc. on 6.

Valuation

Metric BIORQ EIGRQ Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.80 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 67.44 4.37 10.73
Earnings yield 0.00% (601.00%) (28.84%)
Free cash flow yield 0.00% (594.47%) (23.03%)

Profitability

Metric BIORQ EIGRQ Biotechnology median
Gross margin 85.79% 99.85% 65.16%
Operating margin (6,809.06%) (455.12%) 0.00%
Net margin (3,527.85%) (475.26%) 0.00%
Free cash flow margin (5,165.88%) (474.11%) 0.00%
Return on equity 27.98% (367.00%) (57.72%)
Return on assets (128.19%) (94.31%) (49.22%)
Return on invested capital 0.00% (3,674.55%) 0.00%

Growth

Metric BIORQ EIGRQ Biotechnology median
Revenue growth (TTM) 347.00% 16.98% 5.64%
EPS growth (last fiscal year) (57.40%) 27.11% —
Revenue growth, 5-year CAGR (87.44%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIORQ EIGRQ Biotechnology median
Debt to equity (0.18) (2.84) 0.00
Current ratio 0.05 0.71 4.73
Net debt to EBITDA (0.47) (0.22) 0.96

Dividend

Metric BIORQ EIGRQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BIORQ EIGRQ Biotechnology median
Market cap 2.49m 2.55m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack